The drug, which stoked hope against Covid-19 because it works on inflammation, didn’t significantly shorten patients’ hospital stays in a study involving 420 people, Sanofi said in a statement.
PARIS: Sanofi said the rheumatoid arthritis medicine Kevzara failed to work against the new coronavirus, joining a growing list of treatments that were tried and discarded in the pandemic.
The drug, which stoked hope against Covid-19 because it works on inflammation, didn’t significantly shorten patients’ hospital stays in a study involving 420 people, Sanofi said in a statement.
Already a subscriber? Log in.
Limited time offer:
Just RM5 per month.
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!
